檢索結果 - Sunghyun Kang

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Identification of a sequence within U5 required for human immunodeficiency virus type 1 to stably maintain a primer binding site complementary to tRNA(Met)

    Identification of a sequence within U5 required for human immunodeficiency virus type 1 to stably maintain a primer binding site complementary to tRNA(Met) 由 Sunghyun Kang, Zhixin Zhang, Casey D. Morrow

    出版 1997
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Selective inhibition of calcineurin-NFAT signaling by blocking protein–protein interaction with small organic molecules

    Selective inhibition of calcineurin-NFAT signaling by blocking protein–protein interaction with small organic molecules 由 Michael H. A. Roehrl, Sunghyun Kang, J. A. Aramburu, Gerhard Wagner, Anjana Rao, Patrick G. Hogan

    出版 2004
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Potent and Orally Active Small-Molecule Inhibitors of the MDM2−p53 Interaction

    Potent and Orally Active Small-Molecule Inhibitors of the MDM2−p53 Interaction 由 Shanghai Yu, Dongguang Qin, Sanjeev Shangary, Jianyong Chen, Guoping Wang, Ke Ding, Donna McEachern, Su Qiu, Zaneta Nikolovska‐Coleska, Rebecca S. Miller, Sunghyun Kang, Dajun Yang, Shaomeng Wang

    出版 2009
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Inhibition of urease-mediated ammonia production by 2-octynohydroxamic acid in hepatic encephalopathy

    Inhibition of urease-mediated ammonia production by 2-octynohydroxamic acid in hepatic encephalopathy 由 Diana Evstafeva, Filip Ilievski, Yinyin Bao, Zhi Luo, Boris Abramovic, Sunghyun Kang, Christian Steuer, Elita Montanari, Tommaso Casalini, Dunja Simičić, Dario Sessa, Stefanita-Octavian Mitrea, Katarzyna Pierzchała, Cristina Cudalbu, Chelsie E. Armbruster, Jean‐Christophe Leroux

    出版 2024
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    A Potent and Orally Active Antagonist (SM-406/AT-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment

    A Potent and Orally Active Antagonist (SM-406/AT-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment 由 Qian Cai, Haiying Sun, Yuefeng Peng, Jianfeng Lü, Zaneta Nikolovska‐Coleska, Donna McEachern, Liu Liu, Su Qiu, Chao‐Yie Yang, Rebecca S. Miller, Yi Han, Tao Zhang, Duxin Sun, Sunghyun Kang, Ming Guo, Lance Leopold, Dajun Yang, Shaomeng Wang

    出版 2011
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition

    Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition 由 Sanjeev Shangary, Dongguang Qin, Donna McEachern, Meilan Liu, Rebecca S. Miller, Su Qiu, Zaneta Nikolovska‐Coleska, Ke Ding, Guoping Wang, Jianyong Chen, Denzil Bernard, Jian Zhang, Yipin Lu, Qingyang Gu, Rajal B. Shah, Kenneth J. Pienta, Xiaolan Ling, Sunghyun Kang, Ming Guo, Yi Sun, Dajun Yang, Shaomeng Wang

    出版 2008
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: